{"id":"W2772378626","doi":"10.1136/gutjnl-2017-314562","title":"Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)","year":2017,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Genentech; Danone; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Placebo; Crohn's disease; Internal medicine; Adverse effect; Clinical endpoint; Gastroenterology; Randomized controlled trial; Clinical trial; Surgery; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003582838,0.00230915,0.004473754,0.0006048745,0.0006119839,0.001336859,0.001147306,0.00277144,0.01012077],"category_scores_gemma":[0.003340296,0.001221841,0.002105281,0.0005959535,0.00157406,0.001520844,0.0006556504,0.0036168,0.001864513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007915556,"about_ca_system_score_gemma":0.001339948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007602666,"about_ca_topic_score_gemma":0.00170201,"domain_scores_codex":[0.9982001,0.001064396,0.0001144145,0.0002414747,0.0001053022,0.0002742369],"domain_scores_gemma":[0.997809,0.0005595449,0.0005086804,0.0002362941,0.0001341856,0.0007523345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9922627,0.002443101,0.0001850403,0.0002243427,0.0002116106,0.00002557227,0.00002171479,0.00006589105,0.0009768496,0.00006850259,0.000367746,0.003146966],"study_design_scores_gemma":[0.9789788,0.02013211,0.0003305088,0.000009987762,0.00006787184,0.00001483595,0.000004111215,0.0000518827,0.00006087556,0.00004535383,0.0002990229,0.000004473334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9406718,0.008439963,0.002497133,0.001644302,0.003159011,0.0330402,0.004741904,0.0003825495,0.005423242],"genre_scores_gemma":[0.9292572,0.005486246,0.005603787,0.004163976,0.00212885,0.03798693,0.00404883,0.00006805536,0.01125613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01012077,"threshold_uncertainty_score":0.03385741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02432890172643057,"score_gpt":0.3382449471919582,"score_spread":0.3139160454655276,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}